Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical budesonide in pediatric Crohn's-related upper gastrointestinal disease
2020-004168-24Phase 3Active
- Sponsor
- Medical University of Warsaw
- Start
- Jan 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of budesonide in Crohn's disease and gastrointestinal conditions, sponsored by Medical University of Warsaw. Primary endpoint: Endoscopic and histopathological remission. Started Jan 2021; status: active.
02
Drugs
budesonide
03
Conditions
Crohn's diseasegastrointestinal conditions
Beyond the preview
Go deeper on 2020-004168-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004168-24.